Together, these results reveal a novel strategy to improve mitochondrial metabolism in human CD8 CAR-T cells by silencing MCJ, and they show that CD19-BBz/shMCJ CD8 CAR-T cells outperformed the standard CD8 CAR-T cells against human Nalm6 B-ALL cells. This evidence concerns the gene CD8A and acute lymphoblastic leukemia.